Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bi-con-02 (1 trial)
rituximab (rituxan) (2 trials)
Arthritis (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Breast Neoplasms (Phase 1)
Lymphoma (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Trials (3 total)
Trial APIs (2 total)